YahooSeptember 28, 2026 at 9:58 AM NY29 Days Ago
Why This Regeneron Eye Rival Just Catapulted More Than 120%
Kodiak Sciences stock skyrocketed Monday on a double win for its potential rivals to Regeneron Pharmaceuticals' blockbuster eye drug, Eylea.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
